Berry Genomics Co.,Ltd (SHE:000710)
China · Delayed Price · Currency is CNY 9.15
+0.23 (2.58%)
Sep 1, 2026, 3:04 PM CST
Berry Genomics Co.,Ltd Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 235.78 | 379.51 | 383.07 | 338.15 | 333.56 | 417.89 |
Trading Asset Securities | 2.82 | 2.82 | 17.03 | 13.86 | 4.51 | 3.82 |
Cash & Short-Term Investments | 238.6 | 382.33 | 400.1 | 352.01 | 338.07 | 421.7 |
Cash Growth | -35.58% | -4.44% | 13.66% | 4.12% | -19.83% | -33.39% |
Accounts Receivable | 562.84 | 549.34 | 695.17 | 815.21 | 1,063 | 1,109 |
Other Receivables | 51.62 | 56.05 | 76.45 | 4.97 | 14.51 | 34.07 |
Receivables | 614.45 | 605.38 | 771.62 | 820.18 | 1,077 | 1,143 |
Inventory | 176.3 | 176.76 | 194.91 | 229.3 | 230.95 | 233.88 |
Prepaid Expenses | - | 0.08 | 0.01 | 0.14 | 0.21 | 1.88 |
Other Current Assets | 102.27 | 79.52 | 72.45 | 71.37 | 80.15 | 105.88 |
Total Current Assets | 1,132 | 1,244 | 1,439 | 1,473 | 1,727 | 1,907 |
Property, Plant & Equipment | 514.84 | 519.91 | 459.07 | 923.42 | 1,101 | 1,131 |
Long-Term Investments | 194.52 | 187.75 | 177.19 | 48.45 | 138.26 | 279.07 |
Goodwill | 13.43 | 13.43 | 13.43 | 13.43 | 13.43 | 13.43 |
Other Intangible Assets | 62.36 | 66.4 | 31.68 | 49.67 | 51.6 | 52.21 |
Long-Term Accounts Receivable | - | - | 0.31 | - | - | - |
Long-Term Deferred Tax Assets | 148.22 | 150.42 | 144.07 | 151.27 | 104.8 | 63.93 |
Long-Term Deferred Charges | 97 | 102.24 | 89.77 | 48.44 | 41.04 | 46.71 |
Other Long-Term Assets | - | - | 30.11 | 33.49 | 26.66 | 27.05 |
Total Assets | 2,162 | 2,284 | 2,385 | 2,741 | 3,203 | 3,520 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 230.62 | 272.91 | 287.51 | 292.48 | 278.9 | 339.93 |
Accrued Expenses | 37.84 | 52.41 | 55.81 | 64.95 | 63.14 | 66.16 |
Short-Term Debt | 108.64 | 154.32 | 113.42 | 202.64 | 203.69 | 190.54 |
Current Portion of Long-Term Debt | 11.47 | - | - | 42.3 | - | - |
Current Portion of Leases | - | 11.55 | 3.63 | 12.95 | 13 | 9.44 |
Current Income Taxes Payable | 10.55 | 2.91 | 3.9 | 11.91 | 0.38 | 13.44 |
Current Unearned Revenue | 117.22 | 119.66 | 103.49 | 110.75 | 103.56 | 90.55 |
Other Current Liabilities | 16.91 | 22.24 | 22.81 | 25.11 | 42.05 | 58.52 |
Total Current Liabilities | 533.27 | 635.99 | 590.56 | 763.09 | 704.72 | 768.58 |
Long-Term Debt | 10.01 | - | - | 42.18 | 126.6 | 185.7 |
Long-Term Leases | 98.85 | 107.29 | 43.24 | 3.5 | 4.88 | 13.62 |
Long-Term Unearned Revenue | 11.03 | 10.94 | 10.87 | 11.02 | 12.07 | 3.66 |
Long-Term Deferred Tax Liabilities | 25.01 | 25.92 | 24.9 | 26.77 | 25.89 | 24.46 |
Total Liabilities | 708.17 | 780.14 | 669.56 | 846.56 | 874.17 | 996.02 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 353.52 | 353.52 | 353.52 | 353.52 | 354.61 | 354.61 |
Additional Paid-In Capital | 1,158 | 1,163 | 1,159 | 1,156 | 1,211 | 1,160 |
Retained Earnings | -100.26 | -56.32 | 145.39 | 337.82 | 765.02 | 1,020 |
Treasury Stock | - | - | - | - | -44.52 | -44.52 |
Comprehensive Income & Other | 10.58 | 16.41 | 21.1 | 16.5 | 15.39 | 0.63 |
Total Common Equity | 1,422 | 1,476 | 1,679 | 1,864 | 2,301 | 2,490 |
Minority Interest | 31.7 | 27.85 | 35.69 | 30.57 | 27.94 | 33.51 |
Shareholders' Equity | 1,454 | 1,504 | 1,715 | 1,895 | 2,329 | 2,524 |
Total Liabilities & Equity | 2,162 | 2,284 | 2,385 | 2,741 | 3,203 | 3,520 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 228.97 | 273.15 | 160.28 | 303.58 | 348.17 | 399.3 |
Net Cash (Debt) | 9.62 | 109.18 | 239.82 | 48.43 | -10.11 | 22.4 |
Net Cash Growth | -85.89% | -54.47% | 395.21% | - | - | -91.81% |
Net Cash Per Share | 0.03 | 0.31 | 0.68 | 0.14 | -0.03 | 0.06 |
Filing Date Shares Outstanding | 378.16 | 353.52 | 353.52 | 353.52 | 353.52 | 353.52 |
Total Common Shares Outstanding | 378.16 | 353.52 | 353.52 | 353.52 | 353.52 | 353.52 |
Working Capital | 598.36 | 608.09 | 848.53 | 709.9 | 1,022 | 1,138 |
Book Value Per Share | 3.76 | 4.18 | 4.75 | 5.27 | 6.51 | 7.04 |
Tangible Book Value | 1,346 | 1,396 | 1,634 | 1,801 | 2,236 | 2,425 |
Tangible Book Value Per Share | 3.56 | 3.95 | 4.62 | 5.09 | 6.33 | 6.86 |
Buildings | - | 317.47 | 317.47 | 606.22 | 684.23 | 684.08 |
Machinery | - | 647.34 | 623.32 | 638.82 | 591.45 | 553.45 |
Construction In Progress | - | 9.51 | - | 230.8 | 290.95 | 267.6 |